Cargando…
An effective platform for cancer immunotherapy: pooled knockin targeting for genome engineering
Autores principales: | Jin, Ke, Zhang, Long, Zhou, Fangfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293244/ https://www.ncbi.nlm.nih.gov/pubmed/32532958 http://dx.doi.org/10.1038/s41392-020-0208-9 |
Ejemplares similares
-
Cancer Environment Immunotherapy: targeting TGF-β finds its way towards tissue healing and vasculature remodeling
por: Jin, Ke, et al.
Publicado: (2021) -
Targeting FMRP: A new window for cancer immunotherapy
por: Zhang, Yaguang, et al.
Publicado: (2023) -
Tumor‐derived microparticles in tumor immunology and immunotherapy
por: Ma, Jingwei, et al.
Publicado: (2020) -
Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy [Image: see text]
por: Borst, Jannie, et al.
Publicado: (2021) -
WNK1, a molecular crowding sensor, links phase separation to cellular physiological stress
por: Lan, Tinghui, et al.
Publicado: (2023)